Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
JW (Cayman) Therapeutics Co. Ltd. ( (HK:2126) ) has provided an announcement.
JW (Cayman) Therapeutics Co. Ltd. held its Annual General Meeting on June 26, 2025, where all proposed ordinary resolutions were approved by poll. Key resolutions included the adoption of the company’s audited financial statements, re-election of directors, and re-appointment of Deloitte Touche Tohmatsu as auditor, reflecting strong shareholder support and stability in the company’s governance.
More about JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on developing and providing innovative cell-based therapies.
Average Trading Volume: 2,362,219
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.25B
For a thorough assessment of 2126 stock, go to TipRanks’ Stock Analysis page.